3 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 3 |
Follow Gallbladder Diseases: new trials by email Literature Review of Gallbladder Diseases trials Research Report on Gallbladder Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer MEK 162, Gemcitabine, Oxaliplatin - Biliary Tract Carcinoma, Gallbladder Carcinoma | Phase 1 | Withdrawn | University Health Network, Toronto | 2015-06-01 | 2018-02-19 | |
| Transvaginal Cholecystectomy Using Endoscopic Assistance cholecystectomy. - Cholelithiasis, Cholecystitis | Phase 1 | Withdrawn | University of Missouri-Columbia | 2009-01-01 | 2016-09-30 | |
| Effect of Benadryl Sedation During ERCP or EUS Benadryl versus Placebo - Gallbladder Disease, Gallstones | Phase 1 | Withdrawn | University of Rochester | 2005-07-01 | 2015-09-18 |
Abdominal Pain (1) · Biliary Dyskinesia (1) · Cholecystitis (1) · Cholelithiasis (1) · Gallbladder Neoplasms (1) · Gallstones (1) · Jaundice (1) · Neoplasm Metastasis (1) · Pancreatitis (1) · Recurrence (1)
Biliary Tract Diseases (3) · Digestive System Diseases (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bile Duct Diseases (1) · Biliary Tract Neoplasms (1) · Calculi (1) · Cholecystolithiasis (1) · Cholelithiasis (1) · Common Bile Duct Diseases (1) · Digestive System Neoplasms (1) · Disease Attributes (1) · Hyperbilirubinemia (1) · Neoplasms (1)
Cholecystectomy (1) · Gemcitabine (1) · Oxaliplatin (1)
University Health Network, Toronto (1) · University of Missouri-Columbia (1) · University of Rochester (1)
Benedict Maliakkal, MD (1) · Brent Miedema, MD (1) · Jennifer Knox, M.D. (1)